Symposium S1A: Different PD models – policy, economics, outcome, growth |
S1A-2 |
UK model – Why UK leads in the PD utilization rate in Europe
Davies, Simon (UK)
|
S1A-3 |
Australia-NZ model – Why a discrepancy in PD penetration
rate between Australia and New Zealand?
Pollock, Carol (Australia)
|
S1A-4 |
Mexico model – Can the model be adopted in Latin America?
Paniagua, Ramon (Mexico)
|
Symposium S1B: Peritoneal Pathology |
S1B-2 |
Encapsulating peritoneal sclerosis - Is it preventable?
Kawanishi, Hideki (Japan)
|
S1B-3 |
The merits of new PD solutions - Are they worth the cost?
Krediet, Raymond (The Netherlands)
|
Symposium S1C: Cardiovascular disease
|
S1C-1 |
The latest understanding of mechanism for progression of cardiovascular disease in PD patients
Stenvinkel, Peter (Sweden)
|
S1C-2 |
Can we control inflammation and oxidative stress?
Pecoits-Filho, Roberto (Brazil)
|
S1C-3 |
Sympathetic over-activity - a hidden enemy in dialysis patients
Blankestijn, Peter (The Netherlands)
|
Symposium S1D: Adequacy of Dialysis |
S1D-1 |
The impact of the ISPD guideline on dialysis and fluid management in peritoneal dialysis patients
Burkart, John (USA)
|
S1D-3 |
Adequacy of dialysis in pediatric patients (P)
Fischbach, Michel (France)
|
Symposium S2A: Peritonitis |
S2A-1 |
Gram negative peritonitis – The Achilles heel to PD?
Szeto, Cheuk-Chun (Hong Kong)
|
S2A-2 |
Mechanism of emergence of antibiotic resistance – Implication in CAPD peritonitis treatment
Yuen, Kwok-Yung (Hong Kong)
|
S2A-3 |
Treatment of peritonitis in pediatric patients (P)
Warady, Bradley (USA)
|
Symposium S2B: Mesothelial Cell Studies |
S2B-2 |
Mesothelial cell transplantation
Van den Born, Jacob (The Netherlands)
|
S2B-3 |
Peritoneal fibrosis Intervention
Kaneko, Kayo (Japan)
|
Symposium S2C: Nutritional Care (N) |
S2C-1 |
How to improve patient’s appetite and achieve adequate nutrition in vegetarian?
Patel, Chhaya (India)
|
S2C-2 |
Application of dietetic knowledge by nurses
Sevick, Mary Ann (USA)
|
Symposium S2D: Residual Renal Function |
S2D-1 |
How CAPD preserves RRF? Same for APD?
Blake, Peter (Canada)
|
S2D-2 |
Therapeutic options for preservation of RRF
Li, Philip Kam-Tao (Hong Kong)
|
S2D-3 |
How to manage anuric patients?
Davies, Simon (UK)
|
Symposium S3A: PD, APD and HD |
S3A-1 |
Lessons learned from PD and HD patients outcome comparison
and the strategy for developing PD-HD as complimentary therapy
Burkart, John (USA)
|
S3A-2 |
Combined and supplemental HD-PD – Is it cost-effective? How is dialysis prescribed?
Kawanishi, Hideki (Japan)
|
S3A-3 |
Advances in technology in APD,Tidal PD and Continuous Flow PD
Dell’Aquilla, Roberto (Italy)
|
S3A-4 |
Telemedicine in home
Nakamoto, Hidetomo (Japan)
|
Symposium S3B: Diabetic PD patients |
S3B-1 |
Can we overcome the predestination of diabetic patients for poor survival? Perspective from pre- to post-dialysis?
Kim, Yong-Lim (Korea)
|
S3B-2 |
Treatment targets for diabetic PD patients – any evidence?
Huang, Chiu-Ching (Taiwan)
|
S3B-3 |
Peripheral vascular disease in diabetic PD patients
Heikki, Saha (Finland)
|
S3B-4 |
Experience sharing of diabetic renal nursing (N)
Ng, Suk-Yi (Hong Kong)
|
Symposium S3C: Peritoneal inflammation and transport |
S3C-1 |
Peritoneal inflammation - What is new?
Devuyst, Olivier (Belgium)
|
Symposium S3D: Management of cardiovascular disease in adult and paediatric patients |
S3D-2 |
Cardiovascular risks 'hidden' in PD patients since childhood (P)
Geary, Denis (Canada)
|
S3D-3 |
How to prevent sudden death?
Herzog, Charles (USA)
|
S3D-4 |
Cardiac interventions advances in PD patients
Hemmelgarn, Brenda (Canada)
|
Symposium S4A: Calcium, phosphate and bone |
S4A-1 |
An overview of pathophyiology of hyperphosphatemia and vascular calcification
Stompor, Tomasz (Poland)
|
S4A-3 |
Treatment of renal osteodystrophy and hyperphospatemia in pediatric patients – how is it different from adults (P)
Schaefer, Franz (Germany)
|
Symposium S4B: Obstacles for PD development in different areas |
S4B-1 |
The decline of PD utilization in N. America – Reasons and possible solutions
Finkelstein, Fredric (USA)
|
S4B-2 |
The problem in Japan – Too rich? Too scared?
Kawaguchi, Yoshindo (Japan)
|
S4B-3 |
The rise of PD in Asia – What are the problems ahead?
Abraham, Georgi (India)
|
S4B-4 |
PD in Africa – What do Africans need?
Ben Abdallah, Taieb (Tunisia)
|
Symposium S4D: Peritonitis and exit site care |
S4D-1 |
What contributes to difference in peritonitis rate between centers and countries?
Pecoits-Filho, Roberto (Brazil)
|
S4D-2 |
Identifying and tackling the risk factors of peritonitis
Chow, Kai-Ming (Hong Kong)
|
S4D-3 |
Home visit experience sharing in city and rural areas (N)
Antony, Sinoj (India)
|
S4D-4 |
A critical appraisal of various exit site care methods – antiseptics and topical antibiotic application (N)
Prowant, Barbara (USA)
|
Symposium S5B: AGEs, GDPs and ‘biocompatible’ PDF |
S5B-1 |
Peritoneal and Extraperitoneal effect of GDPs and AGEs
De Vriese, An (Belgium)
|
Symposium S5C: Paediatric PD issues (P) |
S5C-1 |
The role of PD in acute renal failure
Yap, Hui Kim (Singapore)
|
S5C-3 |
PD Solutions for Paediatric Patients
Schroder, Cornelius (The Netherlands)
|
S5C-4 |
Benefits of APD
Chiu, Man-Chun (Hong Kong)
|
Symposium S5D: Taking care of geriatric patients |
S5D-1 |
How to improve survival of geriatric PD patients?
Hiramatsu, Makoto (Japan)
|
S5D-2 |
How to improve quality of life of geriatric PD patients?
Finkelstein, Fredric (USA)
|
S5D-3 |
Special training need of elderly patients (N)
Law, Man-Ching (Hong Kong)
|
Symposium S6A: Nutrition in PD |
S6A-1 |
Body composition analysis in adult and pediatric patients –
How reliable they are? How useful they are clinically? (P)
Woodrow, Graham (UK)
|
S6A-2 |
Optimal body fat mass and ways to prevent obesity in PD
Johnson, David (Australia)
|
Symposium S6D: Care for carers (N) |
S6D-1 |
Care of family members of the patients
Price, Valerie (Canada)
|
S6D-2 |
Care of professionals
Bernardini, Judith (USA)
|
S6D-3 |
Training needs of staff and on-going education resources
Kong, Irene Lim-Lim (Hong Kong)
|
S6D-4 |
Extended nursing roles in PD
Figueiredo, Ana (Brazil)
|
Symposium S7A: Rehabilitation of PD patients |
S7A-1 |
Importance of exercise and exercise prescription in PD patients
Lo, Wai-Kei (Hong Kong)
|
S7A-2 |
Running social rehabilitation programs for patients (N)
Price, Valerie (Canada)
|
Symposium S7B: Special need of young patients (P) |
S7B-1 |
Nutrition and Growth in for PD children
Schaefer, Franz (Germany)
|
S7B-2 |
The special need of adolescent PD patients
Watson, Alan (UK)
|
S7B-3 |
Anemia Management in pediatric PD patients
Warady, Bradley (USA)
|
Symposium S7D: Long term PD survivors |
S7D-2 |
Young adults dialyzed since very young – A special entity (P)
Ishikura, Kenji (Japan)
|
Symposium S8A: Fluid management and dialysis compliance (N) |
S8A-1 |
Methodology of assessment of fluid status and ultrafiltration problems
Woodrow, Graham (UK)
|
S8A-2 |
Strategic approach to achieve salt and fluid balance
Wang, Tao (China)
|
S8A-3 |
Detecting dialysis non-compliance and how to educate patients on compliance
Chow, Josephine (Australia)
|
Symposium S8B: Anemia management and Fe therapy |
S8B-1 |
PRCA 'epidemic' – mystery completely revealed? Is it safe to give subcutaneous EPO to PD patients?
Locatelli, Francesco (Italy)
|
S8B-2 |
Intravenous and oral Fe therapy – indications, benefits and harms
Johnson, David (Australia)
|
S8B-3 |
Hyporesponsiveness to EPO therapy – strategy of management
Macdougall, Iain (UK)
|
Symposium S8C: Animal Studies |
S8C-1 |
Lessons learnt from animal studies on PD
Lameire, Norbert (Belgium)
|
Debate 1 |
|
Is aggressive use of statins to reduce LDL justified?
For: Pollock, Carol (Australia)
Against: Locatelli, Francesco (Italy)
|
Debate 2 |
|
Topic: CAPD vs APD at first line therapy
For CAPD: Li, Philip Kam-Tao (Hong Kong)
|
Debate 3 |
|
Should we routinely screen for cardiovascular disease in the asymptomatic patients?
For: Prichard, Sarah (Canada)
Against: Lameire, Norbert (Belgium)
|
Gambro Lunch Symposium |
|
L-Gambro-2
The effect of sodium removal on blood pressure and volume status - Results from the Deltasol Study
Davies, Simon (UK)
Impact of new solutions on volume status of PD patients
Lameire, Norbert (Belgium)
|
Kirin Lunch Symposium |
|
The power of simplify anemia management by long lasting erythropoietic action
Locatelli, Francesco (Italy)
|
Fresenius Lunch Symposium |
|
L-Fresenius-1
Quality management issues
Woods, Feidlhim (Ireland)
|
|
L-Fresenius-2
Quality assurance in PD
Jorres, Achim (Germany)
|
|
L-Fresenius-3
Key success factors for quality PD program
Nayak, Shivanand(India)
|
GSK Lunch Symposium |
|
L-GSK-1
Metabolic Syndrome in Peritoneal Dialysis
Johnson, David (Australia)
|
|
L-GSK-2
Use of Rosiglitazone in Peritoneal dialysis
Szeto, Cheuk-Chun (Hong Kong)
|
Baxter Symposium |
|
SymBaxter-1
"PD in the well and fit patient" - an underutilized modality?
Davies, Simon (UK)
|
|
SymBaxter-3
“PD in high transporters and in the elderly” - maximizing the success of the therapy
Li, Philip Kam-Tao (Hong Kong)
|
